Lilly, Regeneron Among Firms Chosen for FDA Fast Plant Pilot

Lilly, Regeneron among firms chosen for FDA fast plant pilot

Eli Lilly, Regeneron, and five other drugmakers will take part in an FDA pilot designed to make it quicker and easier to set up manufacturing plants.

Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing

Eli Lilly, Regeneron and five others join the FDA PreCheck Pilot Program to boost US drug manufacturing. Read more here.

A new FDA strategy aims to get medicines to the market faster

The FDA has chosen Eli Lilly and Regeneron to participate in a new pilot program aimed at speeding up the development and approval of domestic drug manufacturing facilities, CNBC reports.  The initiative is designed to modernize how the agency oversees construction and readiness of pharmaceutical production sites by engaging with companies earlier in the process. […]

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.

FDA Pilot Aims to Speed Up New U.S. Drug Manufacturing Plants

The FDA selected seven companies for a pilot program aimed at reducing delays in opening new U.S. pharmaceutical manufacturing facilities.